Randomized Controlled Study of a Computer Stop Order Versus Routine Practice When Trimethoprim/Sulfamethoxazole is Ordered Concurrently With Warfarin
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- University of Pennsylvania
- Enrollment
- 1,971
- Primary Endpoint
- Reduce concomitant orders for warfarin and tmp/smx
Study Overview
Brief Summary
To determine if a computerized stop order will reduce the number of concurrent trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic ordering system while a patient is hospitalized.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Masking
- Single (Participant)
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •All resident physicians and nurse practitioners involved in inpatient care.
Exclusion Criteria
- Not provided
Arms & Interventions
computerized alert
An automatic electronic stop of the tmp/sulfa or warfarin order whenever a resident or nurse practitioner places an order for tmp/sulfa with an already active warfarin order, or when ordering both simultaneously
Intervention: Trimethoprim/Sulfamethoxazole and Warfarin (Drug)
2 Current practice
Current practice of the pharmacist recommending cessation of concurrent warfarin and tmp/sulfa orders
Intervention: Trimethoprim/Sulfamethoxazole and Warfarin (Drug)
Outcomes
Primary Outcomes
Reduce concomitant orders for warfarin and tmp/smx
Time Frame: 7 months
Secondary Outcomes
- Determine if computerized stop order will increase risk for inadvertent cessation of warfarin(7 months)
- Determine if computerized stop order will increase risk of delay of treatment with tmp/sulfa when determined to be necessary for treatment(7 months)
